EirGenix Statistics

Total Valuation

EirGenix has a market cap or net worth of TWD 18.78 billion. The enterprise value is 16.22 billion.

Market Cap	18.78B
Enterprise Value	16.22B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

EirGenix has 302.34 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	302.34M
Shares Outstanding	302.34M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	-1.04%
Owned by Insiders (%)	1.41%
Owned by Institutions (%)	7.57%
Float	192.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.33
PB Ratio	2.12
P/TBV Ratio	2.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-21.58
EV / Sales	16.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.07

Financial Position

The company has a current ratio of 7.44, with a Debt / Equity ratio of 0.14.

Current Ratio	7.44
Quick Ratio	6.29
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	-0.77
Interest Coverage	-146.69

Financial Efficiency

Return on equity (ROE) is -8.00% and return on invested capital (ROIC) is -5.77%.

Return on Equity (ROE)	-8.00%
Return on Assets (ROA)	-5.48%
Return on Invested Capital (ROIC)	-5.77%
Return on Capital Employed (ROCE)	-9.56%
Revenue Per Employee	971,190
Profits Per Employee	-751,423
Employee Count	1,000
Asset Turnover	0.09
Inventory Turnover	1.18

Taxes

In the past 12 months, EirGenix has paid 1.76 million in taxes.

Income Tax	1.76M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.23% in the last 52 weeks. The beta is 0.40, so EirGenix's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-27.23%
50-Day Moving Average	62.69
200-Day Moving Average	77.75
Relative Strength Index (RSI)	48.17
Average Volume (20 Days)	298,985

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EirGenix had revenue of TWD 971.19 million and -751.42 million in losses. Loss per share was -2.46.

Revenue	971.19M
Gross Profit	218.25M
Operating Income	-962.59M
Pretax Income	-749.67M
Net Income	-751.42M
EBITDA	-711.01M
EBIT	-962.59M
Loss Per Share	-2.46

Full Income Statement

Balance Sheet

The company has 3.79 billion in cash and 1.23 billion in debt, giving a net cash position of 2.56 billion or 8.46 per share.

Cash & Cash Equivalents	3.79B
Total Debt	1.23B
Net Cash	2.56B
Net Cash Per Share	8.46
Equity (Book Value)	8.85B
Book Value Per Share	29.27
Working Capital	4.52B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -525.02 million and capital expenditures -1.09 billion, giving a free cash flow of -1.61 billion.

Operating Cash Flow	-525.02M
Capital Expenditures	-1.09B
Free Cash Flow	-1.61B
FCF Per Share	-5.33

Full Cash Flow Statement

Margins

Gross margin is 22.47%, with operating and profit margins of -99.11% and -77.37%.

Gross Margin	22.47%
Operating Margin	-99.11%
Pretax Margin	-77.19%
Profit Margin	-77.37%
EBITDA Margin	-73.21%
EBIT Margin	-99.11%
FCF Margin	n/a

Dividends & Yields

EirGenix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	n/a
Earnings Yield	-4.00%
FCF Yield	-8.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EirGenix has an Altman Z-Score of 8.16 and a Piotroski F-Score of 2.

Altman Z-Score	8.16
Piotroski F-Score	2